FIELD: medicine, cardiology. SUBSTANCE: patient should be injected with propranolol at daily dosage of 10- 20 mg, hypothiazide 12.5 mg/d and APF inhibitor up to maximum tolerant dosage. The present innovation provides improved effect in treating combined pathology at decreasing the number of therapeutic side effects. EFFECT: higher efficiency of therapy. 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING THE SEVERITY DEGREE OF CHRONIC HEART FAILURE IN PATIENTS WITH CARDIOVASCULAR DISEASES | 1999 |
|
RU2186519C2 |
| METHOD FOR PREDICTING STAGE OF CHRONIC RENAL FAILURE IN NEPHROLOGICAL PATIENTS | 2000 |
|
RU2195162C2 |
| METHOD FOR DETECTING STAGE OF CHRONIC RENAL FAILURE IN NEPHROLOGICAL PATIENTS | 2000 |
|
RU2195161C2 |
| METHOD FOR EVALUATING FUNCTIONAL STATE OF LEFT VENTRICLE MYOCARDIUM BY DETERMINING CARDIAC MUSCLE DYSFUNCTION INDEX | 2000 |
|
RU2182459C2 |
| METHOD FOR SELECTING ANTIRECIDIVATION THERAPY OF THE FIBRILLATION PAROXYSMS AND ATRIAL FLUTTER ARISEN FOR THE FIRST TIME | 1999 |
|
RU2192776C2 |
| METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2010 |
|
RU2428978C1 |
| METHOD TO MATCH AN EFFECTIVE DOSAGE OF BETA-ADRENOBLOCKERS IN ISCHEMIC PATIENTS | 2000 |
|
RU2180796C1 |
| METHOD FOR IMPROVING DIASTOLIC FUNCTION OF LEFT VENTRICLE AT INITIAL STAGES OF CARDIOMYOPATHIES IN CHILDREN WITH INSULIN-DEPENDENT DIABETES MELLITUS | 2000 |
|
RU2200019C2 |
| METHOD OF TREATING PATIENTS SUFFERING CHRONIC CARDIAC FAILURE COMPROMISED TYPE 2 DIABETES | 2010 |
|
RU2421218C1 |
| METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2428980C1 |
